James Davey - author of the article - Why Dr. Martens' Reduction in Discounting Exposes a gap in Retail Strategy

This article is by James Davey, from Rockhot Consulting Group 

Dr. Martens just announced flat sales projections whilst reducing discounting across their direct-to-consumer channel.

The market’s treating this like a pricing decision. It’s not.

It’s an operational foundation problem. Most scaling retailers can’t solve it because they lack what I’ll call the commercial synthesis capacity, the ability to convertability convert brand strength into sustainable revenue without promotional dependency.

The Measurement Illusion Discounting Creates

This is the first place the synthesis gap shows up, with measurement. If we look at what actually happened at Dr. Martens: DTC sales fell 7% in the 13-week period to December 28, they reduced discounting, whilst wholesale revenues jumped 9.3%.

But look at the detail: full price DTC sales rose 2% year on year.

That’s not a demand problem. That’s a customer segmentation reality that promotional noise was obscuring.

When you’re running 20% off site-wide every other week, you’re not measuring brand strength. You’re measuring your ability to train customers to wait for discounts.

Volume grows, visibility collapses. You lose the ability to distinguish full price demand from discount trainer behaviour.

This creates what I call measurement illusion. Your analytics models show ROAS looks fine, your conversion rates hold steady. But you’re systematically degrading the commercial foundation underneath.

You’re building a customer base conditioned to expect promotional subsidy.

Dr. Martens’ CEO Ije Nwokorie framed it perfectly: “We have continued to improve the quality of our revenue through a disciplined approach to promotions.”

Quality of revenue. Not volume of revenue. That distinction requires operational infrastructure most retailers don’t have.

What “Flat Sales With Improved Profitability” Actually Reveals

When Dr. Martens says they’re projecting flat sales whilst improving profitability, they’re telling you they’ve solved a synthesis problem. They’ve built the capacity to answer: which customer segments drive sustainable margin without promotional subsidy?

The numbers prove it. DTC full price revenue was up 6% year on year, the mix of full price to clearance up 5%, and an increase of 10% in the percentage of new consumers coming to full price versus discounts.

That’s not luck. That’s sophisticated segmentation.

But here’s where it gets interesting. They can only measure this because they removed the promotional noise.
This is the same measurement illusion, now viewed through customer segmentation rather than topline revenue. You’re acquiring customers at 20% off and customers at full price simultaneously. Your attribution models can’t tell you which cohort has higher lifetime value because the discount-trained customers contaminate your retention curves.

The hidden cost structure that discounting obscures isn’t just margin erosion on individual transactions.
It’s the operational overhead of managing promotional complexity across channels. It’s the customer service burden of discount expectation. It’s the strategic fog that prevents you from understanding your actual unit economics by segment.

Most retailers can’t make this transition. They lack the cross-functional capacity to coordinate across marketing, finance, and commercial teams on different timelines whilst maintaining board-level alignment on a unified strategy that supersedes departmental KPIs.

The Channel Strategy Synthesis Problem

This is the same synthesis gap, now exposed through channel economics rather than promotions. Dr. Martens’ wholesale growth offsetting DTC decline isn’t channel diversification success.

It’s integration failure.

Here’s the structural problem. When you reduce discounting on your DTC channel but your wholesale partners continue promotional activity, you’ve created a channel conflict that requires synthesis capacity to resolve.

The economics reveal why this matters. Almost every company that reports EBIT margins by channel showed meaningfully higher EBIT rates at wholesale versus DTC, because fulfilment, logistics, heavy marketing costs, technology, and increased returns (4X higher when selling DTC) can quickly erode gross margin gains.

But Dr. Martens can’t just retreat to wholesale. They need DTC for customer data, for brand control, for margin opportunity on full-price sales.

The synthesis problem is this: how do you maintain brand positioning across channels when wholesale partners are discounting your product whilst you’re trying to train DTC customers to buy at full price?

This requires operational infrastructure that connects brand strategy, channel economics, and customer segmentation into a coherent commercial system.

You need to know which customer segments shop which channels. What their lifetime value looks like across touchpoints. How promotional activity in one channel affects behaviour in another.

Most £700k-£70m retailers don’t have this synthesis layer. Marketing optimises ROAS. Finance tracks margin by channel. Commercial managed wholesale relationships. Each function performs, but no one connects them into a unified commercial system.

Why The CLV vs ROAS Shift Exposes The Integration Gap

There’s a prediction floating around that LTV will be a headliner at unBoxed 2026.
That’s not about customer preference changing. That’s about competitive pressure from brands that have solved the synthesis problem forcing laggards into margin compression.

Here’s why. ROAS still shows whether advertising produced revenue, but it ignores the cost structure, retention curve, and customer quality signals that determine profitability. As acquisition costs rise and attribution weakens, ROAS optimises the wrong outcomes.

Dr. Martens already recognises this: “When we are targeting a consumer who has a high propensity to buy full price, we will not be targeting them with a discount message, because we know that they are motivated by that full price offering.”

That requires customer data platform infrastructure that can segment by propensity, track behaviour across channels, and feed targeting logic back into acquisition systems.

Most retailers don’t have this. They’ve got marketing teams running campaigns optimised for in-channel ROAS. Finance teams tracking contribution margin by product. Commercial teams managing inventory. But no operational capacity to connect these data streams into actionable customer segmentation that drives targeting decisions.

The gap isn’t technical. It’s commercial synthesis capacity.

Translation between attribution models, unit economics, and inventory reality isn’t optional, it’s the operating system.

Without that synthesis capacity, you default to optimising for volume because it’s the only metric everyone agrees on. And volume optimisation leads straight back to promotional dependency.

Brand Value As Measurable Commercial Architecture

Dr. Martens has a natural advantage here: product durability creates lifetime value opportunity.

Their customers demonstrate “a collecting stage” behaviour pattern. The goal is to grow full price sales and be less reliant upon discounting.

But converting brand heritage into pricing power requires operational infrastructure that prevents discount-trained cohorts contaminating full-price segments.

This isn’t marketing aspiration. It’s measurable commercial architecture.

You need to know which acquisition channels bring in full-price buyers versus discount seekers. What’s the retention curve difference between cohorts acquired at full price versus 20% off. How does promotional frequency affect repeat purchase behaviour 12 months out.

Then you need the operational capacity to act on those insights across functions.

Marketing needs to adjust targeting and creative. Finance needs to model the margin impact of shifting acquisition mix. Commercial needs to manage inventory allocation between full-price and clearance.

And all of this needs to happen whilst maintaining board-level alignment on a strategy that accepts short-term revenue decline in exchange for improved customer quality and margin structure.

That’s the synthesis gap. Not the strategy. The execution.

Why Most Can’t Execute This Transition

Dr. Martens’ sales decline underscores the challenge facing CEO Ije Nwokorie as he tries to set the business on a path to long-term growth while navigating weak demand in key markets. It’s a balancing act that has forced the company to sacrifice near-term sales to protect margins.

The structural requirement: board-level alignment on unified strategy superseding departmental KPIs.
Most retailers can’t get there because they lack the synthesis capacity to connect specialist functions into coherent strategic direction.

You’ve got marketing teams measured on acquisition volume and ROAS. Finance teams measured on margin by channel. Commercial teams measured on revenue growth. Each function optimises within its domain, but there’s no operational layer connecting these specialist activities into a unified commercial system.

The result is predictable. Marketing keeps running promotional campaigns because they drive conversion. Finance keeps pushing for margin improvement through cost reduction. Commercial keeps chasing revenue growth through volume.

And nobody’s measuring customer quality or lifetime value because it requires cross-functional data integration that doesn’t exist.
Dr. Martens can execute this transition because they’ve got the scale to build the infrastructure and the board-level alignment to accept short-term pain for long-term gain.

Most £700k-£70m retailers don’t have either.

They understand the logic. They know promotional dependency degrades customer quality. They recognise that ROAS optimisation without lifetime value consideration leads to margin compression.

But they can’t execute. They lack three critical elements:

The synthesis capacity to coordinate across functions. The infrastructure to measure customer quality by segment. The board-level alignment to accept revenue decline whilst building sustainable commercial architecture.

That’s not a strategy problem. That’s an operational foundations problem.

Dr. Martens’ discount reduction isn’t a pricing decision…it’s evidence of synthesis capacity. And that capacity, not intent, is what most retailers lack.

About the Author

James Davey has spent 35 years embedded in retail, including board-level accountability for nine-figure revenue P&L’s. He now works as a fractional director with £700k-£70m product-based retailers through his consultancy Digital Blueprint, part of the Rockethot Consulting Group.

His work focuses on the synthesis gap most businesses can’t access through permanent hiring or specialist advisory… connecting marketing, finance, and commercial functions into coherent strategic direction that converts brand strength into sustainable revenue without promotional dependency.